$OMDA

Cook Steven L. sold $117K of OMDA

Cook Steven L. (Chief Financial Officer) sold 6,800 shares of Omada Health, Inc. (OMDA) at $17.23 ($0.12M total) on 2026-06-15 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Cook Steven L.
Published Jun 16, 2026, 8:57 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 16, 2026, 9:03 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$OMDA
Neutral
high confidence
Mentioned
$OMDA
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$OMDANeutralLow
01

Why it matters

The disclosure may slightly influence short-term sentiment, but the 10b5-1 structure typically lowers the informational content versus discretionary selling.

02

Market read

Traders may monitor OMDA for any follow-on insider activity or concurrent fundamental catalysts, but this specific filing is unlikely to drive a major repricing alone.

03

What to watch

The article provides only the sale size and plan type; it does not indicate whether other insiders bought, whether the company had concurrent news, or whether the sale was for diversification/taxes.

Relevance 3/10Novelty 6/10Timing: Filed today; sale dated 2026-06-15

Background

This is an SEC Form 4 insider transaction for Omada Health, reporting an officer’s open-market sale executed under a pre-arranged 10b5-1 plan.

Company-level read

Ticker impact

$OMDANeutralHigh confidence
Context

Omada Health CFO Steven Cook sold 6,800 shares in an open-market transaction under a pre-arranged 10b5-1 plan.

Expected impact

Low likelihood of a sustained price move solely from this Form 4; any impact is likely short-lived.

Evidence & confidence

The filing is a disclosed insider sale (S) with an explicit pre-arranged 10b5-1 plan, reducing the probability of it reflecting new negative information.

Market effects

No sector-level read-through; this is company-specific insider transaction disclosure.

None indicated.

None indicated.

Counterpoint

Even with a 10b5-1 plan, repeated insider selling can still be interpreted by some traders as confidence erosion, especially if it coincides with other negative signals not mentioned here.

Key entities

  • Omada Health, Inc.

    Company whose CFO insider sale is disclosed on Form 4.

  • Steven L. Cook

    Chief Financial Officer who sold 6,800 shares.

  • 10b5-1 plan

    Pre-arranged plan that governs the timing/amount of insider trades.

Related articles

$OMDAHigh

Omada Health, Inc. (OMDA): Results of Operations and Financial Condition

Omada Health, Inc. (OMDA) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99 2 q2fy26pressrelease.htm EX-99 Document Omada Health Reports Second Quarter 2026 Results and Announces CEO Transition • Revenue Grew 43% and Total Members Increased 45% Year over Year, with Gross Margin Reaching a New Quarterly Record • Company Announces Sean Duffy to Becom